Document Library
Filter by country
Africa
Angola
Benin
Burkina Faso
Burundi
Cameroon
Central African Republic (the)
Chad
Comoros (the)
Congo (the)
Cote d'Ivoire
Congo, DR
Eritrea
Ethiopia
The Gambia
Ghana
Guinea-Bissau
Guinea
Kenya
Lesotho
Liberia
Madagascar
Malawi
Mali
Mauritania
Mozambique
Niger
Nigeria
Rwanda
Sao Tome and Principe
Senegal
Sierra Leone
South Sudan
Tanzania, UR
Togo
Uganda
Zambia
Zimbabwe
South-East Asia
Bangladesh
Bhutan
China
Korea, DPR
India
Indonesia
Myanmar
Nepal
Sri Lanka
Timor Leste
Americas
Cuba
Haiti
Honduras
Nicaragua
Bolivia
Guyana
Europe
Albania
Armenia
Azerbaijan
Bosnia-Herzegovina
Georgia
Kyrgyzstan
Moldova
Tajikistan
Turkmenistan
Ukraine
Uzbekistan
Western Pacific
Cambodia
Kiribati
Lao PDR
Mongolia
Papua New Guinea
Solomon Islands
Vietnam
Eastern Mediterranean
Afghanistan
Djibouti
Pakistan
Somalia
Sudan (the)
Yemen
Filter by type
Country
Africa
South-East Asia
Americas
Europe
Western Pacific
Eastern Mediterranean
Documents
Annual Reports
AMC Documents
Country Documents
Evaluations
Financial Reports
Guidelines and Forms
Legal
Strategy
Supply and Procurement
Policies
White papers
Gavi Fact Sheets
Gavi Publications
The Evidence Base
Gavi Bulletin
Other Publishers
Board Minutes
Committee minutes
Audit
Spanish
Russian
IRC reports
Portuguese
Annual Contributions and Proceeds
Cash Receipts
Advocacy
Resource mobilisation
German
COVID-19 situation report
COVAX documents
COVAX AMC
Gavi Process Guidelines
Gavi Programme Funding Guidelines
Programme audit
Internal audit
Investigation
Reports to the Board
Other (IA)
COVAX data brief
DHI
VIS
News
AMC Updates
Gavi Features
Press Releases
Roi
Statements
Gavi Blogs
Vaccineswork
Theme - Pentavalent
Top stories
3rd donor pledging
3rd donor pledging featured
Partner news
IATI
Social media toolkit
Audio Visual
Infographics
Presentations
Videos
Galleries
Market shaping
Phase I - innovations
Phase II - innovations
VIPS
Gender
Board
Committee
Members
Donor
Japan
RFP
Country managed evaluations
Old RFP
Centralised evaluations (EAC)
3rd donor pledging announcements
Types of support
Human papillomavirus
Inactivated polio vaccine
Japanese encephalitis
Measles and measles-rubella
Meningitis A
Oral cholera
Pentavalent
Pneumococcal
Rotavirus
Typhoid
Yellow fever
Health system strengthening
Hexavalent
DTP-containing booster
Board meetings
COVAX roll-out
Africa COVAX roll-out
Americas COVAX roll-out
Eastern Mediterranean COVAX roll-out
Europe COVAX roll-out
SE Asia COVAX roll-out
Western Pacific COVAX roll-out
Decentralised Evaluations
Decentralised Evaluations pages
Knowledge Products
Discussion Paper
Annual Evaluation Reports
Other learning products
CSO
CSO news
CSO story
CSO learning brief
Africa
Angola
Benin
Burkina Faso
Burundi
Cameroon
Central African Republic (the)
Chad
Comoros (the)
Congo (the)
Cote d'Ivoire
Congo, DR
Eritrea
Ethiopia
The Gambia
Ghana
Guinea-Bissau
Guinea
Kenya
Lesotho
Liberia
Madagascar
Malawi
Mali
Mauritania
Mozambique
Niger
Nigeria
Rwanda
Sao Tome and Principe
Senegal
Sierra Leone
South Sudan
Tanzania, UR
Togo
Uganda
Zambia
Zimbabwe
South-East Asia
Bangladesh
Bhutan
China
Korea, DPR
India
Indonesia
Myanmar
Nepal
Sri Lanka
Timor Leste
Americas
Cuba
Haiti
Honduras
Nicaragua
Bolivia
Guyana
Europe
Albania
Armenia
Azerbaijan
Bosnia-Herzegovina
Georgia
Kyrgyzstan
Moldova
Tajikistan
Turkmenistan
Ukraine
Uzbekistan
Western Pacific
Cambodia
Kiribati
Lao PDR
Mongolia
Papua New Guinea
Solomon Islands
Vietnam
Eastern Mediterranean
Afghanistan
Djibouti
Pakistan
Somalia
Sudan (the)
Yemen
Annual Reports
AMC Documents
Manufacturers related
Strategic Demand Forecast
Target Product Profile
Legal Agreements
Remaining offer amount
Country Documents
Approved proposals
Comprehensive multi-year plans, Financial sustainability plans, National Immunisation Strategy
Country co-financing information sheet
Data quality audit
Decision Letters and Partnerships Agreement
The joint appraisal report and Multi-Stakeholder Dialogue
Targeted country assistance plans
HSS evaluation
HSS tracking study
Annual progress reports
COVAX Technical Assistance Plans
Evaluations
CSO 2012
Full country evaluations
Second evaluation
IFFIm evaluation
HSS evaluation
TCA
Other studies
CSO 2018
Financial Reports
Guidelines and Forms
General
Japanese encephalitis vaccine
Meningitis A vaccine
Pneumococcal vaccine
Rotavirus vaccine
Typhoid vaccine
Yellow fever vaccine
HSS support
CCEOP support
Report on and renew support
TCA
Additional guidance
Joint appraisals
Tools and templates
Legal
Strategy
Phase 4
Phase 5
Phase 3
Phase 2
Phase 1
Risk
Supply and Procurement
Roadmaps
Base demand forecast
Detailed product profiles
Strategy 2016-20
Policies
Corporate
Programmatic
White papers
Gavi Fact Sheets
Gavi Publications
Japanese
Gavi progress reports
Arabic
Investment opportunity
The Evidence Base
Gavi Bulletin
Other Publishers
Board Minutes
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Decisions
Programme
2020
2021
2022
2023
2024
2025
2026
Committee minutes
PPC
EAC
IC
AFC
GC
Audit
Spanish
Russian
IRC reports
Portuguese
Annual Contributions and Proceeds
Cash Receipts
Advocacy
Resource mobilisation
German
COVID-19 situation report
COVAX documents
COVAX AMC
COVAX AMC VR
COVAX AMC TA
COVAX AMC CCE
COVAX AMC CDS (EA)
COVAX AMC CDS (NB)
Legal 1
Legal 2
Gavi Process Guidelines
Human papillomavirus vaccine
Measles and measles-rubella vaccines
Application Process
Application Kit
Analysis
Vaccine Information & Switches
Ongoing Portfolio Management, Reporting & Renewals
Financial Management & Reporting
Joint-Appraisal & Multi Stakeholder Dialogue
IPV
Meningococcal vaccines
Pneumococcal vaccine
Rotavirus vaccine
Typhoid vaccine
Yellow fever vaccine
Malaria vaccine
Cholera vaccine (OCV)
Gavi process guidelines 5.0
Vaccine switch information
Hexavalent guidelines
Ebola
Human rabies vaccine for post-exposure prophylasis
DTP guidelines
Gavi process guidelines 6.0
Gavi Programme Funding Guidelines
Zero-dose
Maintain, Restore & Strengthen
Demand, Communities and Gender
Supply Chain & Cold Chain Equipment
Data
Leadership, Management and Coordination
Immunisation Financing
Gavi Programme Funding Guidelines – Main
Additional Resources
Programme audit
Internal audit
Investigation
Reports to the Board
Other (IA)
COVAX data brief
DHI
Case studies & technical briefs
Practical guides
Digital Health Information Strategy
Research publications
VIS
VIS 2018
AMC Updates
Gavi Features
Press Releases
COVAX latest
Gavi partner
Roi
Statements
Gavi Blogs
Vaccineswork
Primary health care
Universal health care
Equity
Gender
Outbreaks
Technology and innovation
Antimicrobial resistance
Climate change
Urbanisation
Identity
Opinions
Country stories
COVID-19
Most read
Review
Partner
Featured VW articles
Featured Large VW article
MTR
Theme - Pentavalent
Top stories
HEHR
3rd donor pledging
Alliance partners
3rd donor pledging featured
Partner news
IATI
Social media toolkit
Angola
Benin
Burkina Faso
Burundi
Cameroon
Central African Republic (the)
Chad
Comoros (the)
Congo (the)
Cote d'Ivoire
Congo, DR
Eritrea
Ethiopia
The Gambia
Ghana
Guinea-Bissau
Guinea
Kenya
Lesotho
Liberia
Madagascar
Malawi
Mali
Mauritania
Mozambique
Niger
Nigeria
Rwanda
Sao Tome and Principe
Senegal
Sierra Leone
South Sudan
Tanzania, UR
Togo
Uganda
Zambia
Zimbabwe
Manufacturers related
Strategic Demand Forecast
Target Product Profile
Legal Agreements
Remaining offer amount
Approved proposals
Approved proposals
Comprehensive multi-year plans, Financial sustainability plans, National Immunisation Strategy
Comprehensive multi-year plans, Financial sustainability plans, National Immunisation Strategy
Country co-financing information sheet
Country co-financing information sheet
Data quality audit
Data quality audit
Decision Letters and Partnerships Agreement
Decision Letters and Partnerships Agreement
The joint appraisal report and Multi-Stakeholder Dialogue
The joint appraisal report and Multi-Stakeholder Dialogue
Targeted country assistance plans
Targeted country assistance plans
HSS evaluation
HSS evaluation
HSS tracking study
HSS tracking study
Annual progress reports
Annual progress reports
COVAX Technical Assistance Plans
COVAX Technical Assistance Plans
CSO 2012
Full country evaluations
FCE 2016
FCE 2015
FCE 2014
FCE 2013
Second evaluation
IFFIm evaluation
HSS evaluation
Gavi managed evaluations
Summaries
TCA
Other studies
CSO 2018
General
Japanese encephalitis vaccine
Meningitis A vaccine
Pneumococcal vaccine
Rotavirus vaccine
Typhoid vaccine
Yellow fever vaccine
HSS support
CCEOP support
Report on and renew support
Tools and templates
Additional info
TCA
Additional guidance
Financial management
Programming guidance
Requirements for implementation
Gender related barriers
Immunisation financing
Leadership management coordination
Improving data quality
Joint appraisals
Tools and templates
Phase 4
Phase 5
Phase 3
Phase 2
Phase 1
Risk
Roadmaps
Vaccine roadmap
CCE roadmap
Diagnostics roadmaps
Base demand forecast
Detailed product profiles
Strategy 2016-20
COVAX latest
Gavi partner
Corporate
Programmatic
Infographics
Presentations
Videos
Galleries
Japanese
Gavi progress reports
Arabic
Investment opportunity
Primary health care
Universal health care
Equity
Gender
Outbreaks
Technology and innovation
Antimicrobial resistance
Climate change
Urbanisation
Identity
Opinions
Seth Berkley
Ngozi Okonjo-Iweala
Anuradha Gupta
Sania Nishtar
Country stories
COVID-19
Explainer
Blog
Key news
COVAX
COVAX AMC articles
Most read
1 Trending
2 Trending
3 Trending
4 Trending
5 Trending
6 Trending
Review
Partner
Featured VW articles
Featured Large VW article
MTR
Phase I - innovations
Phase II - innovations
VIPS
Vaccine roadmap
CCE roadmap
Diagnostics roadmaps
Bangladesh
Bhutan
China
Korea, DPR
India
Indonesia
Myanmar
Nepal
Sri Lanka
Timor Leste
Cuba
Haiti
Honduras
Nicaragua
Bolivia
Guyana
Albania
Armenia
Azerbaijan
Bosnia-Herzegovina
Georgia
Kyrgyzstan
Moldova
Tajikistan
Turkmenistan
Ukraine
Uzbekistan
Cambodia
Kiribati
Lao PDR
Mongolia
Papua New Guinea
Solomon Islands
Vietnam
2019
26 June
26 June Presentations
4 Dec
4 Dec presentations
2018
6 June
28 Nov OLD
6 June presentations
28 Nov presentations
28 Nov
28 Nov Pre-Board briefings
6 June pre-board briefings
28 Nov NEW
2017
14 June
7 July
29 Nov
14 June presentations
29 Nov presentations
29 Nov NEW
14 June Tech briefings
14 June NEW
2016
22 June
7 Dec
22 June presentations
7 Dec presentations
22 June Tech briefings
2015
10 June
2 Dec
10 June presentations
2 Dec presentations
2 Dec Tech briefings
10 June Tech briefings
2014
18 June
10 Dec
18 June presentations
10 Dec presentations
10 Dec Tech briefings
18 June Tech briefings
2013
11 June
21 Nov
11 June presentations
21 Nov presentations
2012
12 June
4 Dec
12 June presentations
4 Dec presentations
2011
7 July
16 Nov
7 July presentations
16 Nov presentations
2010
16 June
30 Nov
16 June presentations
30 Nov presentations
2009
Decisions
Programme
Governance
Investment
Audit
Evaluation
2020
19 March
11 May
24 June
24 June presentations
30 July
30 July Presentations
29 Sept
29 Sept Presentations
15-17 Dec
15-17 Dec Presentations
2021
22 March
22 March Presentations
23-24 June
23-24 June Presentations
28 Sept
28 Sept Presentations
30 Nov - 2 Dec
30 Nov - 2 Dec Presentations
Board Decision
2022
22-23 June
22-23 June Presentations
7-8 December
7-8 December Presentations
Board Decision
2023
Board Decision
26-27 June
26-27 June Presentations
6-7 December
6-7 December Presentations
2024
6-7 June
6-7 June Presentations
Board Decision
4-5 December
4-5 December Presentations
2025
24-25 July
24-25 July Presentations
Board Decision
3-4 December
3-4 December Presentations
2026
1-2 July
1-2 July Presentations
Board Decision
26 June
26 June Presentations
4 Dec
4 Dec presentations
6 June
28 Nov OLD
6 June presentations
28 Nov presentations
28 Nov
28 Nov Pre-Board briefings
6 June pre-board briefings
28 Nov NEW
14 June
7 July
29 Nov
14 June presentations
29 Nov presentations
29 Nov NEW
14 June Tech briefings
14 June NEW
22 June
7 Dec
22 June presentations
7 Dec presentations
22 June Tech briefings
10 June
2 Dec
10 June presentations
2 Dec presentations
2 Dec Tech briefings
10 June Tech briefings
18 June
10 Dec
18 June presentations
10 Dec presentations
10 Dec Tech briefings
18 June Tech briefings
11 June
21 Nov
11 June presentations
21 Nov presentations
12 June
4 Dec
12 June presentations
4 Dec presentations
7 July
16 Nov
7 July presentations
16 Nov presentations
16 June
30 Nov
16 June presentations
30 Nov presentations
PPC
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2020
2021
2022
2023
2024
2025
EAC
2009
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2020
2021
2022
2023
2024
2025
IC
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2020
2021
2022
2023
2024
AFC
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2020
2021
2022
2023
2024
2025
GC
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2020
2021
2022
2023
2024
2025
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2020
2021
2022
2023
2024
2025
2009
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2020
2021
2022
2023
2024
2025
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2020
2021
2022
2023
2024
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2020
2021
2022
2023
2024
2025
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2020
2021
Recommendation
2022
Recommendation
2023
Recommendation
2024
Recommendation
2025
Seth Berkley
Ngozi Okonjo-Iweala
Anuradha Gupta
Sania Nishtar
Committee
Members
Japan
Tools and templates
Additional info
Financial management
Programming guidance
Requirements for implementation
Gender related barriers
Immunisation financing
Leadership management coordination
Improving data quality
Governance
Investment
Audit
Evaluation
Afghanistan
Djibouti
Pakistan
Somalia
Sudan (the)
Yemen
FCE 2016
FCE 2015
FCE 2014
FCE 2013
Gavi managed evaluations
Summaries
HEHR
Alliance partners
Explainer
Blog
Key news
COVAX
COVAX key articles
COVAX AMC articles
Human papillomavirus
Inactivated polio vaccine
Japanese encephalitis
Measles and measles-rubella
Meningitis A
Oral cholera
Pentavalent
Pneumococcal
Rotavirus
Typhoid
Yellow fever
Health system strengthening
Hexavalent
DTP-containing booster
19 March
11 May
24 June
24 June presentations
30 July
30 July Presentations
29 Sept
29 Sept Presentations
15-17 Dec
15-17 Dec Presentations
1 Trending
2 Trending
3 Trending
4 Trending
5 Trending
6 Trending
COVAX key articles
COVAX AMC VR
COVAX AMC TA
COVAX AMC CCE
COVAX AMC CDS (EA)
COVAX AMC CDS (NB)
Legal 1
Legal 2
Africa COVAX roll-out
Americas COVAX roll-out
Eastern Mediterranean COVAX roll-out
Europe COVAX roll-out
SE Asia COVAX roll-out
Western Pacific COVAX roll-out
22 March
22 March Presentations
23-24 June
23-24 June Presentations
28 Sept
28 Sept Presentations
30 Nov - 2 Dec
30 Nov - 2 Dec Presentations
Board Decision
Recommendation
Human papillomavirus vaccine
Measles and measles-rubella vaccines
Application Process
Application Kit
FPP Application Guidelines & Materials
Standalone EAF Application Materials & Guidelines
Standalone Vaccine Application Materials & Guidelines
Standalone TCA Application Materials & Guidelines
Standalone CCEOP Application Materials & Guidelines
Standalone Innovation Top-up Application Materials & Guidelines
Gavi Middle Income Countries (MICs)
Analysis
Vaccine Information & Switches
Ongoing Portfolio Management, Reporting & Renewals
Financial Management & Reporting
Joint-Appraisal & Multi Stakeholder Dialogue
IPV
Meningococcal vaccines
Pneumococcal vaccine
Rotavirus vaccine
Typhoid vaccine
Yellow fever vaccine
Malaria vaccine
Cholera vaccine (OCV)
Gavi process guidelines 5.0
Vaccine switch information
Hexavalent guidelines
Ebola
Human rabies vaccine for post-exposure prophylasis
DTP guidelines
Gavi process guidelines 6.0
Gavi 6.0 application kit
FPP Application Guidelines & Materials
Standalone EAF Application Materials & Guidelines
Standalone Vaccine Application Materials & Guidelines
Standalone TCA Application Materials & Guidelines
Standalone CCEOP Application Materials & Guidelines
Standalone Innovation Top-up Application Materials & Guidelines
Gavi Middle Income Countries (MICs)
Zero-dose
Maintain, Restore & Strengthen
Demand, Communities and Gender
Supply Chain & Cold Chain Equipment
Data
Leadership, Management and Coordination
Immunisation Financing
Gavi Programme Funding Guidelines – Main
Additional Resources
Discussion Paper
22-23 June
22-23 June Presentations
7-8 December
7-8 December Presentations
Board Decision
Recommendation
Board Decision
26-27 June
26-27 June Presentations
6-7 December
6-7 December Presentations
Recommendation
Case studies & technical briefs
Practical guides
Digital Health Information Strategy
Research publications
VIS 2018
6-7 June
6-7 June Presentations
Board Decision
4-5 December
4-5 December Presentations
Recommendation
CSO news
CSO story
CSO learning brief
24-25 July
24-25 July Presentations
Board Decision
3-4 December
3-4 December Presentations
Gavi 6.0 application kit
1-2 July
1-2 July Presentations
Board Decision
14 Review of decisions No paper pdf
1
Board -2022 -Mtg -03 -Doc 14
Report to the Board
7-8 December 2022
Subject Review of decisions
Agenda item 14
No paper
Board -2022 -Mtg -03 -Doc 14
Report to the Board
7-8 December 2022
Subject Review of decisions
Agenda item 14
No paper
15 Closing remarks No paper pdf
1
Board -2022 -Mtg -03 -Doc 15
Report to the Board
7-8 December 2022
Subject Cl osing remarks
Agenda item 15
No paper
Board -2022 -Mtg -03 -Doc 15
Report to the Board
7-8 December 2022
Subject Cl osing remarks
Agenda item 15
No paper
Malaria vaccine roadmap: public summary (2022)
Gavi Board approved a funding window for malaria vaccines in December 2021 to support the use of malaria vaccines in routine immunisation programmes. This document is the public summary of the market shaping roadmap for malaria vaccines.
